Latham & Watkins LLP represents the underwriters in the transaction. Silverback Therapeutics, Inc. (Silverback) announced the pricing of its initial public offering of 11,500,000 shares of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now